Cargando…
Precision Oncology for Cancer Immunotherapies in Early-Phase Clinical Trials
The clinical development of cancer drugs is rapidly moving from empirical “one drug fits all” or development-by-tumor-type approaches towards more personalized treatment models. A deeper understanding of cancer and the immune system, novel technologies, and powerful analytics have fueled an increase...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875515/ https://www.ncbi.nlm.nih.gov/pubmed/31595386 http://dx.doi.org/10.1007/s11523-019-00678-w |